➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
Merck
McKinsey
Medtronic

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Lidocaine - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for lidocaine and what is the scope of freedom to operate?

Lidocaine is the generic ingredient in forty-five branded drugs marketed by Astrazeneca, Noven, Carlisle, Aleor Dermaceuticals, Alkem Labs Ltd, Amneal Pharms, Belmora Llc, Cosette, Fougera Pharms Inc, Glenmark Pharms Ltd, Macleods Pharms Ltd, Novast Labs, Septodont Inc, Strides Pharma, Sungen Pharma, Taro, Teligent Pharma Inc, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Mylan Technologies, Rhodes Pharms, Teikoku Pharma Usa, Scilex Pharms Inc, Akorn, Abbott, Abraxis Pharm, Am Regent, Aurobindo Pharma Ltd, B Braun Medical Inc, Bel Mar, Dell Labs, Elkins Sinn, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Miles, Mylan Labs Ltd, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Pharmaton, Meridian Medcl Techn, Dentsply Pharm, Bionpharma Inc, Sagent Pharms Inc, Watson Labs Inc, Oak Pharms, Hi Tech Pharma, Wockhardt Bio Ag, Actavis Mid Atlantic, Lannett Co Inc, Hikma, Kendall Il, Paco, Powder Pharms, Pfizer, Teva Branded Pharm, Fougera Pharms, Tolmar, Taro Pharms, and Galen Specialty, and is included in one hundred and forty NDAs. There are ten patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Lidocaine has thirteen patent family members in eight countries.

There are twenty-nine drug master file entries for lidocaine. Forty-one suppliers are listed for this compound.

Drug Prices for lidocaine

See drug prices for lidocaine

Drug Sales Revenue Trends for lidocaine

See drug sales revenues for lidocaine

Recent Clinical Trials for lidocaine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
St. Joseph's Healthcare HamiltonPhase 2
Scilex Pharmaceuticals, Inc.N/A
Washington D.C. Veterans Affairs Medical CenterN/A

See all lidocaine clinical trials

Pharmacology for lidocaine
Medical Subject Heading (MeSH) Categories for lidocaine
Paragraph IV (Patent) Challenges for LIDOCAINE
Tradename Dosage Ingredient NDA Submissiondate
LIDODERM PATCH;TOPICAL lidocaine 020612 2009-11-13

US Patents and Regulatory Information for lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Technologies LIDOCAINE lidocaine PATCH;TOPICAL 202346-001 Aug 7, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Hi Tech Pharma LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride SOLUTION;ORAL 040014-001 Jul 10, 1995 AT RX No No   Start Trial   Start Trial   Start Trial
Watson Labs LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 083627-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088331-001 May 17, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 086578-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs Inc LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride JELLY;TOPICAL 040837-001 Mar 23, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Belmora Llc LIDOCAINE lidocaine OINTMENT;TOPICAL 080210-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lidocaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999   Start Trial   Start Trial
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996   Start Trial   Start Trial
Noven DENTIPATCH lidocaine PATCH;TOPICAL 020575-002 May 21, 1996   Start Trial   Start Trial
Noven DENTIPATCH lidocaine FILM, EXTENDED RELEASE;BUCCAL 020575-001 May 21, 1996   Start Trial   Start Trial
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999   Start Trial   Start Trial
Teikoku Pharma Usa LIDODERM lidocaine PATCH;TOPICAL 020612-001 Mar 19, 1999   Start Trial   Start Trial
Noven DENTIPATCH lidocaine FILM, EXTENDED RELEASE;BUCCAL 020575-001 May 21, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
Merck
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.